Health-care company stocks declined. Moderna shares fell after reports that federal health officials are re-evaluating its $590 million contract to help develop a bird-flu vaccine. Shares of Teladoc ...

Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s ...

The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested Nvidia earnings and Trump's latest tariff threats.

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

U.S. stock indexes are slipping, and Wall Street remains subdued following a rough run where worries about the economy ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...